Indefinite Delivery Contract HHSN261201000004I
Award Date
1/25/10
Last Date to Order
1/24/15
Federal Agency
National Cancer Institute
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract was awarded by the National Cancer Institute (NCI) to Duke University's Office of Research Administration Division to support the Cancer Genome Atlas (TCGA) program under the American Recovery and Reinvestment Act (ARRA). The $360,000 single-award contract, without any set-aside designation, tasks Duke University as the prime contractor to recover tissue samples and data from various types of cancer to further the goals of the TCGA program. A $248,400 firm...
This indefinite delivery contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency, to Duke University as the prime contractor. The contract has a ceiling value of $360,000 and supports the Cancer Genome Atlas (TCGA) program, which was funded under the American Recovery and Reinvestment Act (ARRA). Under this IDC, Duke University will provide tissue samples and data from various types of cancer to contribute to the TCGA program. The contract is a task order under the...
This federal contract IDV was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the University of Pittsburgh to support the Cancer Genome Atlas (TCGA) program. The contract, valued at $760,912.68, is an Indefinite Delivery Contract (IDC) that allows NCI to rapidly initiate new preclinical studies and procure tissue samples and data from various cancer types to support the TCGA program, an initiative funded by the American Recovery...
This federal contract IDV was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research. The contract, with a ceiling value of $103,516.60, provides for the acquisition of tissue samples and associated data from various cancer types to support the NCI's Cancer Genome Atlas (TCGA) program, which aims to comprehensively characterize the genomic changes in major cancer types. The contract was...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, to The Johns Hopkins University, a private non-profit research university. The $134,931.50 single-award contract supports the NCI Cancer Genome Atlas Program Tissue Purchase. It is for the recovery and provision of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, including under the American Recovery...
This federal contract IDV was awarded by the National Cancer Institute (NCI), a civilian agency under the Department of Health and Human Services, to support the Cancer Genome Atlas (TCGA) program. The fixed-price, $263,765.60 contract was awarded to the University Health Network (UHN), a non-profit academic health sciences center in Canada, to provide tissue samples and data from various types of cancer for the TCGA program. The contract supports the American Recovery and Reinvestment Act...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization located in New York, NY. The contract, valued at $200,000, supports the NCI's Cancer Genome Atlas (TCGA) program, which aims to collect and analyze tissue samples and data from various cancer types. The initial $120,500 task order under this contract requires the...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Indivumed, Inc. to provide tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The contract has a total ceiling value of $2,712,155.00 and does not have a set-aside designation. The contract consists of three firm-fixed-price delivery orders with a combined total value of $2,259,118.07. The...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The contract, valued at $236,000.00, is part of the NCI Cancer Genome Atlas (TCGA) Program and aims to procure tissue samples and data from various cancer types for the TCGA's comprehensive genomic characterization efforts. The contract was awarded in August...
This federal contract IDV was awarded by the National Cancer Institute (NCI), a civilian agency under the Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization and subsidiary of the Memorial Sloan Kettering Cancer Center. The $96,000 indefinite delivery contract, with a period of performance ending March 31, 2015, is part of the NCI Cancer Genome Atlas Program Tissue Purchase master contract. The contract provides for the...